Efficacy, safety, and tolerability of nivasorexant in adults with binge-eating disorder: A randomized, Phase II proof of concept trial

McElroy, S. L., Coloma, P. M., Berger, B., Guerdjikova, A. I., Joyce, J. M., Liebowitz, M. R., Pain, S., & Rabasa, C. (2023). Efficacy, safety, and tolerability of nivasorexant in adults with binge‐eating disorder: A randomized, Phase II proof of concept trial. International Journal of Eating Disorders, 56(11), 2120–2130. Portico. https://doi.org/10.1002/eat.24039
Authors:
Susan L. McElroy
Preciosa M. Coloma
Benjamin Berger
Anna I. Guerdjikova
J. Mark Joyce
Michael R. Liebowitz
Scott Pain
Cristina Rabasa
Affiliated Authors:
Michael R. Liebowitz
Columbia Affiliation:
Author Keywords:
binge-eating disorder
clinical trial
orexin-1 receptor
phase 2
proof-of-concept
elink
Publication Type:
Article
Unique ID:
10.1002/eat.24039
PMID:
37584285
DOI:
10.1002/eat.24039
Journal:
International Journal of Eating Disorders
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: